Brain, Vol. 118, No. 6, 1601-1612, 1995
© 1995 Guarantors of Brain
review-article |
Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis
1 Department of Neurology, Scientific Institute Ospedale San Raffaele, University of Milan Milan, Italy 2Department of Medical Physics, University of Leicester Leicester 3NMR Research Unit, Institute of Neurology London, UK 4Department of Diagnostic Radiology, Free University Hospital Amsterdam, The Netherlands
Correspondence to:
Correspondence to: Dr Massimo Filippi, Department of Neurology, Scientific Institute Ospedale San Raffaele, Via Olgettina, 6020132 Milan, Italy
In recent years, several segmentation techniques have been developed to quantify brain MRI lesion load in multiple sclerosis and are now being used increasingly for both evaluating the natural history of the disease and monitoring the efficacy of treatment. Such techniques have been applied extensively to conventional T2-weighted images: there is less experience to date with gadolinium-enhanced scans and newer MR parameters which are thought to reflect the more destructive aspects of the pathological process. Manual outlining of lesions on T2-weighted images is moderately accurate when performed by an experienced observer and has been validated in large clinical trials, but is very time consuming. Semi-automated intensity-based techniques appear to be more reproducible, but are still slow to perform. Faster techniques with higher reproducibility are still needed. The correlations between conventional T2 lesion load and clinical outcome is strong in patients seen at first presentation with clinically isolated syndromes suggestive of multiple sclerosis, but much weaker in established multiple sclerosis. The application of quantitative assessment of the MR parameters which are more specific for the disabling aspects of the pathological process (i.e. demyelination, axonal loss and spinal cord involvement) may improve the correlation with clinical status.
multiple sclerosis; MRI; quantitative assessment; lesion volume; disability
Received March 29, 1995. Revised June 28, 1995. Accepted July 22, 1995.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A Minneboo, B. Uitdehaag, P Jongen, H Vrenken, D. Knol, M. van Walderveen, C. Polman, J. Castelijns, and F Barkhof Association between MRI parameters and the MS severity scale: a 12 year follow-up study Multiple Sclerosis, May 1, 2009; 15(5): 632 - 637. [Abstract] [PDF] |
||||
![]() |
B. Benedetti, D.J. Rigotti, S. Liu, M. Filippi, R.I. Grossman, and O. Gonen Reproducibility of the Whole-Brain N-Acetylaspartate Level across Institutions, MR Scanners, and Field Strengths AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 72 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge Multiple Sclerosis: The Role of MR Imaging AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Benner, J. J. Wisco, A. J. W. van der Kouwe, B. Fischl, M. G. Vangel, F. H. Hochberg, and A. G. Sorensen Comparison of Manual and Automatic Section Positioning of Brain MR Images Radiology, April 1, 2006; 239(1): 246 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Tartaglia, S. Narayanan, S. J. Francis, A. C. Santos, N. De Stefano, Y. Lapierre, and D. L. Arnold The Relationship Between Diffuse Axonal Damage and Fatigue in Multiple Sclerosis Arch Neurol, February 1, 2004; 61(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Piras, I Magnano, E D G Canu, K S Paulus, W M Satta, A Soddu, M Conti, A Achene, G Solinas, and I Aiello Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Srinivasan, R. Henry, D. Pelletier, and S. Nelson Standardized, Reproducible, High Resolution Global Measurements of T1 Relaxation Metrics in Cases of Multiple Sclerosis AJNR Am. J. Neuroradiol., January 1, 2003; 24(1): 58 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gonen, D. M. Moriarty, B. S. Y. Li, J. S. Babb, J. He, J. Listerud, D. Jacobs, C. E. Markowitz, and R. I. Grossman Relapsing-remitting Multiple Sclerosis and Whole-Brain N-Acetylaspartate Measurement: Evidence for Different Clinical Cohorts—Initial Observations Radiology, October 1, 2002; 225(1): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Rao, N. Richert, T. Howard, B.K. Lewis, C.N. Bash, H.F. McFarland, and J. A. Frank Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFN{beta}-1b Neurology, September 10, 2002; 59(5): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lowe, M. D. Phillips, J. T. Lurito, D. Mattson, M. Dzemidzic, and V. P. Mathews Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level-Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results Radiology, July 1, 2002; 224(1): 184 - 192. [Abstract] [Full Text] |
||||
![]() |
S. H. Faro, F. B. Mohamed, J. I. Tracy, R. M. Elfont, A. B. Pinus, F. D. Lublin, R. A. Koenigsberg, C. Y. Chen, and F. Y. Tsai Quantitative Functional MR Imaging of the Visual Cortex at 1.5 T as a Function of Luminance Contrast in Healthy Volunteers and Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., January 1, 2002; 23(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Yousry, S. Forderreuther, B. Moriggl, M. Holtmannspotter, T. P. Naidich, A. Straube, and T. A. Yousry Cervical MR Imaging in Postural Headache: MR Signs and Pathophysiological Implications AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1239 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Janardhan and R. Bakshi Quality of Life and Its Relationship to Brain Lesions and Atrophy on Magnetic Resonance Images in 60 Patients With Multiple Sclerosis Arch Neurol, October 1, 2000; 57(10): 1485 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohta, K. Ohta, J. Ma, J. Takeuchi, T. Saida, M. Nishimura, and N. Itoh Clinical and Analytical Evaluation of an Enzyme Immunoassay for Myelin Basic Protein in Cerebrospinal Fluid Clin. Chem., September 1, 2000; 46(9): 1326 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Brex, G J M Parker, S M Leary, P D Molyneux, G J Barker, C A Davie, A J Thompson, and D H Miller Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 627 - 632. [Abstract] [Full Text] |
||||
![]() |
M Kremenchutzky, D Lee, G P A Rice, and G C Ebers Diagnostic brain MRI findings in primary progressive multiple sclerosis Multiple Sclerosis, April 1, 2000; 6(2): 81 - 85. [Abstract] [PDF] |
||||
![]() |
G. P. A. Rice, M. Filippi, and G. Comi Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial Neurology, March 14, 2000; 54(5): 1145 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Moriarty, A. J. Blackshaw, P. R. Talbot, H. L. Griffiths, J. S. Snowden, V. F. Hillier, S. Capener, R. D. Laitt, and A. Jackson Memory Dysfunction in Multiple Sclerosis Corresponds to Juxtacortical Lesion Load on Fast Fluid-Attenuated Inversion-Recovery MR Images AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1956 - 1962. [Abstract] [Full Text] |
||||
![]() |
Y. Miki, R. I. Grossman, J. K. Udupa, L. Wei, M. Polansky, L. J. Mannon, and D. L. Kolson Relapsing-Remitting Multiple Sclerosis: Longitudinal Analysis of MR Images-Lack of Correlation between Changes in T2 Lesion Volume and Clinical Findings Radiology, November 1, 1999; 213(2): 395 - 399. [Abstract] [Full Text] |
||||
![]() |
Rovaris, Comi, M. Rocca, Cercignani, Colombo, Santuccio, and Filippi Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple AJNR Am. J. Neuroradiol., May 1, 1999; 20(5): 813 - 820. [Abstract] [Full Text] |
||||
![]() |
Y. Miki, R. I. Grossman, J. K. Udupa, M. A. van Buchem, L. Wei, M. D. Phillips, U. Patel, J. C. McGowan, and D. L. Kolson Differences between Relapsing-Remitting and Chronic Progressive Multiple Sclerosis as Determined with Quantitative MR Imaging Radiology, March 1, 1999; 210(3): 769 - 774. [Abstract] [Full Text] |
||||
![]() |
M. Filippi, G. Iannucci, C. Tortorella, L. Minicucci, M. A. Horsfield, B. Colombo, M. P. Sormani, and G. Comi Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI Neurology, February 1, 1999; 52(3): 588 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination Neurology, February 1, 1999; 52(3): 599 - 599. [Abstract] [Full Text] |
||||
![]() |
M. Filippi, T. A Yousry, M. A Rocca, C. Pereira, H. Alkadhi, and G. Comi The effect of cross-talk on MRI lesion numbers and volumes in multiple sclerosis using conventional and turbo spin-echo Multiple Sclerosis, December 1, 1998; 4(6): 471 - 474. [Abstract] [PDF] |
||||
![]() |
P D Molyneux, P S Tofts, A Fletcher, B Gunn, P Robinson, H Gallagher, I F Moseley, G J Barker, and D H Miller Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 42 - 47. [Abstract] [Full Text] |
||||
![]() |
J. A. Koziol, S. Wagner, and H.-P. Adams Assessing information in T2-weighted MRI scans from secondary progressive MS patients Neurology, July 1, 1998; 51(1): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Giovannoni, A J. Green, and E J Thompson Are there any body fluid markers of brain atrophy in multiple sclerosis? Multiple Sclerosis, June 1, 1998; 4(3): 138 - 142. [Abstract] [PDF] |
||||
![]() |
S. J. Khoury and H. L. Weiner Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies? Arch Intern Med, March 23, 1998; 158(6): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rovaris, M. Sormanis, M. Rocca, G. Comi, and M. Filippi The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis Multiple Sclerosis, December 1, 1997; 3(6): 382 - 384. [Abstract] [PDF] |
||||
![]() |
L. Wang, H-M Lai, A J Thompson, and D H Miller Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load J. Neurol. Neurosurg. Psychiatry, October 1, 1997; 63(4): 452 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Comi, V Martinelli, and M Filippi Interferon beta treatment in multiple sclerosis: the European clinical trials Multiple Sclerosis, June 1, 1996; 1(6): 317 - 320. [PDF] |
||||







